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Fanconi’s anemia is a rare autosomal recessive disorder 
characterized by congenital malformation, bone marrow 
failure and genomic instability, with a predisposition to 
develop malignancies, especially the leukemias and upper 
aerodigestive tract tumors. Due to inherent characteristics to 
this syndrome, the treatment of such neoplasms is particularly 
difficult. In this paper we report the case of a 24-year-old 
woman with Fanconi’s anemia who developed a squamous 
cell carcinoma of the hypopharynx; she had none of the 
traditional risk factors, such as smoking and alcohol abuse. 
We also briefly review the literature about this topic
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INTRODUCTION
Fanconi’s anemia (McKusick 227650), also known 
as hereditary pancytopenia, is a syndrome characterized 
by blood disorders associated to congenital malforma-
tions, of recessive autosomal inheritance, with clinically 
variable expression. Among the most characteristic clinical 
manifestations we have growth retardation, hypoplastic 
thumbs (or absent) and short radius (or absent). Alongsi-
de other hereditary disorders such as Bloom’s syndrome 
and ataxia telangiectasia, Fanconi’s  anemia is part of the 
group of syndromes marked by genomic instability, and 
this predisposes patients to different types of cancer. In the 
cytogenetic study, the genomic instability is manifested as 
breaks and rearrangements in different chromosomes. 
Fanconi’s anemia treatment is based on support 
measures, medication (steroids, androgens, colony stimula-
ting factors) and, in selected cases, bone marrow allogenic 
transplant. Most patients die due to pancytopenia-related 
blood complications or sepsis. On the other hand, those 
who develop malignant neoplasias, and are not proper 
candidates to surgical treatment, are more prone to the 
adverse effects of radiotherapy and chemotherapy, in 
such a way as to make it even more difficult to plan for 
therapy. 
Hereto, we make a summary review of the litera-
ture and report a case of squamous cell carcinoma of the 
hypopharynx in a young adult with Fanconi’s anemia. 
LITERATURE REVIEW
First described in 1927, Fanconi’s anemia is a rare 
recessive autosomal disorder, with heterogenous genotype 
and phenotype, characterized by constitutional aplastic 
anemia, congenital malformations, chromosome instability 
and predisposition to the development of neoplasia.1,2 Cli-
nical manifestations vary, and include: growth and sexual 
maturation retardation, low stature, skeletal abnormalities 
(radius and thumb), bone marrow aplasia, café au lait spots 
and renal and cardiac malformations. Diagnosis is carried 
out by a cytogenetic analysis that shows a greater trend 
towards chromosome rupture by alkylating agents such 
as mitomycin C and diepoxybutane. 
The genetic basis for Fanconi’s anemia is as com-
plex as its great variation in clinical presentation. There 
are at least eight subtypes (A, B, C, D1, D2, E, F and G), 
each one with a distinct genetic defect. Pathogenesis is 
related to the lack of DNA repair mechanisms, with the 
consequent build up of a large number of mutations. 
Recent studies suggest that Fanconi’s anemia genes, such 
as the genes BRCA1 and BRCA2, act on a final common 
pathway, related to DNA repair.3
Because of this incapacity in keeping genomic in-
tegrity, we see a high degree of chromosome instability. 
Patients have a higher risk of developing neoplasia, which 
increases with the increase in life expectancy.4 The most 
prevalent type is leukemia (especially acute myeloid); 
followed in a descending order by squamous cells car-
cinoma (aerodigestive tract, anus, genital area and skin), 
and brain, liver and renal neoplasias.5 Neoplasias usually 
are seen when the patient is about 16 years of age, and 
with age increase it is not uncommon to see other tumor 
types affecting the same person.6 Moreover, there are 
case reports in which the cancer diagnosis preceded that 
of the syndrome. 
Fanconi’s anemia-associated solid tumors treatment 
is primarily surgical, even with a higher operative risk 
because of bone marrow aplasia.7 Epidermoid carcino-
mas of the head and neck are usually more biologically 
aggressive, in such a way as to require adjuvant therapy. 
However, because of defects on the DNA repair mecha-
nisms, patients are very susceptible to radio and chemo-
therapy side effects, especially myelosuppression. Even 
so, these therapy modalities must be considered when 
surgery is contra-indicated. In such cases, we recommend 
using doses lower than the ones commonly used, tailor-
made regimens (that do not include alkylating agents or 
cisplatin) and the use of radio-protective agents such as 
amifostine.8-10
CASE REPORT
A 24 year old brown and single woman, a student 
that after being diagnosed with Fanconi’s anemia when she 
was 12 years old, started to make regular use of medro-
xyprogesterone and oxymetholone. There are two other 
cases diagnosed in her family: a 21 year old sister, and a 
brother who died at 15 years of age victim of leukemia. 
Her parents are related by kinship. 
The patient, who did not drink or smoke, was 
admitted to a University Hospital because of progres-
sive hoarseness, dysphagia, odynophagia and weight 
loss, with six months of evolution. Initial clinical exam 
showed low weight and height development (weight = 
28.7 kg) (height= 1.32 m), café au lait spots in her torso 
and malnutrition. CBC showed important pancytopenia: 
hemoglobin= 5.9 g/dl, leukocyte count= 800/mm3 and 
platelets = 29.100/mm3. Videolaryngoscopy revealed a 
vegetant and ulcerated lesion, mostly located on the left 
piriform cavity, invading the proximal esophagus (Figure 
1). A neck CT scan showed a soft mass in the hypopharynx 
area involving the left piriform cavity and going from the 
aryepiglottic folds all the way to the arytenoid cartilages, 
with a probable segmentary concentric parietal thickening 
of the upper esophagus. We did not observe enlarged 
lymphnodes (Figure 2). Lesion biopsy revealed an inva-
sive, ulcerated and moderately differentiated squamous 
cell carcinoma. 
During intervention, the patient presented nume-
rous fever episodes with neutropenia, and this caused 
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in dysphagia and odynophagia, and the fever returned, 
which led us to discontinue it (total dose of radiotherapy 
received was 19.8 Gy). The patient developed pneumonia 
together with severe neutropenia (leucocytes 100/mm3), 
and died despite treatment with antibiotics. 
DISCUSSION
In a large number of cases, squamous cell carci-
nomas of the hypopharynx are closely related to tobacco 
and alcohol exposure, usually affecting those above 60 
years of age, mainly males.11 In the case hereby reported 
- a young 24 year old patient, without prior exposure to 
alcohol or tobacco - only the concurrence of another pre-
disposing factor - Fanconi’s anemia, could have explained 
this type of neoplasia. In a study in which they assessed 
754 patients with this syndrome, the authors noticed an 
increase of approximately 500 fold in the incidence of 
head and neck tumors, mainly in females (2:1), and ave-
rage age at diagnosis of 31 years, when compared to the 
general population.12
FINAL COMMENTS
Having seen the great variation in clinical presenta-
tion, the few cases reported in the literature and the high 
morbidity associated to the different forms of treatment, 
we appreciate the great difficulty in approaching head and 
neck neoplasias associated to Fanconi’s anemia. Therefore, 
all effort should be put up in order to detect it early on by 
means of a periodic medical evaluation that must include 
a thorough otorhinolaryngological assessment. 
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Figure 2. Neck CT scan, axial view: tumor mass in the left piriform 
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the prescription of many antibiotic agents in association 
(ceftazidime, amikacin, imipenem, vancomycin, ampho-
tericin B e fluconazole).
The possibility of surgical treatment (total pha-
ryngoesophagectomy with the placement of a retro-ster-
nal gastric tube, bilateral lymphnode clearance, partial 
thyroidectomy and postop radiotherapy) was ruled out 
since the patient did not allow it and would not tolerate 
it. Oncologists counter-indicated chemotherapy, and only 
palliative radiotherapy was used. 
Coinciding with radiotherapy, there was a worsening 
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